Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.942154
Abstract: Immune checkpoint modulation has been a vital therapeutic option in many malignancies, and targeting of novel immune checkpoints, including OX40/OX40L costimulatory signaling, is being assessed in clinical trials. However, little is known about the role…
read more here.
Keywords:
ox40 ox40l;
immune checkpoint;
ductal adenocarcinoma;
ics ox40l ... See more keywords